The European School of Oncology continues the consolidated

The European School of Oncology continues the consolidated tradition of offering an independent,updated and affordable oncological education for all professionals interested in learning to care.

For 2018 there are a number of new initiative that we hope will help fulfilling your need of oncologicalknowledge.

• Renewed e-learning programme on the latest topics in oncology. The format of the e-grandrounds has been enriched with interactive case-discussion, conference reports and controversies.The collaboration with CROH and Nature will ensure up to date issues and the participation of the mostrenowned experts.

• Certificate of Competence in Lymphoma, Breast Cancer, in collaboration with Ulm University, and LungCancer being launched for talented clinical oncologists and related specialists.

• Study grants for young oncologists to spend 3 to 6 months in clinical departments of European cancercentres chosen for their recognized excellence in clinical oncology and education. In 2018, the offer hasbeen extended to include Istituto Nazionale Tumori Milano and Christie Hospital Manchester. Alsopaediatric oncologists and nurses may apply in selected centres.

• Breast Cancer in Young Women International Conference (BCY4) with its state of the art consensus.

• Residential Masterclasses in Clinical Oncology in Europe, Latin America and Eurasia, encompassing casediscussion and direct interaction between participants and teachers.

• Masterclasses for Oncology Nursing, in collaboration with EONS, within the Residential Masterclasses inClinical Oncology or as a self-standing event.

• Advanced/refresher courses in disease specific issues, including Gynecologic Oncology, Head and NeckCancer, Urological malignancies.

• ESO observatories and sessions in lymphomas, breast, prostate, colorectal, lung cancer within prestigiousinternational conferences.

• Patients and advocate empowerment programme.

• Rare cancers programme with the traditional clinical update on rare adult solid cancers in collaborationwith ESMO, RCE, EURACAN and Milan University.

• Residential courses for medical students to build up a knowledgeable community of future medicaloncologists ready to face the challenges of this fascinating profession, in collaboration with ESMO, ESSOand ESTRO.

• Continuing collaboration with EANO, ESGO-ENYGO, ESMO, ESNM, ESSO, ESTRO, ESOP, EONS, EAU, ECCO,SIOPE, OECI and UICC within the common objective of expanding knowledge and teachingmultidisciplinarity.

Looking forward to meeting you at one of the ESO events, in person or online,

Fedro A. Peccatori, MDScientific Director

Alberto Costa, MD CEO

ESO EDUCATION 2017-2018 | 1

2 | ESO EDUCATION 2017-2018

E-ESO ONLINE EDUCATIONAL RESOURCES

e-Sessions (live and recorded on the internet)ePatCare (clinical cases)

MASTERCLASSES

15-18 December 20176th Arab and Southern European Countries Masterclass in Clinical Oncology | Limassol, Cyprus

23-25 February 20183rd ESO Masterclass in Cancer Patient Advocacy | Lisbon, Portugal

24-29 March 201817th ESO-ESMO Masterclass in Clinical Oncology | Nauen OT Groß Behnitz (Berlin), Germany

24-29 March 201811th ESO-EONS Masterclass in Oncology Nursing | Nauen OT Groß Behnitz (Berlin), Germany

18-22 May 20183rd Masterclass on Systematic Reviews in Cancer Care, Guidelines and Research | Belfast, United Kingdom

16-21 June 20187th ESO-SIOP EUROPE Masterclass in Paediatric Oncology | Nauen OT Groß Behnitz (Berlin), Germany

COURSES AND SEMINARS

28 October 20179th Clinical Oncology Update - Onkologia 2017 | Krakow, Poland

2-4 December 20172nd ESO-ESMO-RCE Clinical Update on Rare Adult Solid Cancers | Milan, Italyand University Post-graduate Courses in Clinical Oncology of Rare Adult Solid Cancers | 2018 | Milan, Italy

19-24 July 2018ESMO-ESO Course on Medical Oncology for Medical Students | Valencia, Spain

August 2018ESO-ESSO-ESTRO Multidisciplinary Course in Oncology for Medical Students | Poznan, Poland

27-29 September 2018Update Skills in Head and Neck Surgery and Oncology | Leipzig, Germany

October 201810th Clinical Oncology Update - Onkologia 2018 | Krakow, Poland

INSIDE TRACK CONFERENCES

2-4 November 2017Advanced Breast Cancer Fourth ESO-ESMO International Consensus Conference (ABC4) | Lisbon, Portugal

4-5 November 2017First ABC Global Alliance Meeting | Lisbon, Portugal

17-18 May 20188th ESO-CNIO Familial Cancer Conference | Madrid, Spain

6-8 October 20184th ESO-ESMO Breast Cancer in Young Women International Conference (BCY4) | Lugano, Switzerland

EASTERN EUROPE AND BALKAN REGION PROGRAMME

6-7 October 2017Eastern Europe and Balkan Region Refresher Course on Breast Cancer | Krakow, Poland

Dates to be announced5th ESO-ESMO Eastern Europe and Balkan Region Masterclass in Medical Oncology | Belgrade, Republic of Serbia

20-22 September 20181st ESO-EONS Eastern Europe and Balkan Region Masterclass in Oncology Nursing | Budapest, Hungary

ES

O E

DU

CA

TIO

N 2

017

-20

18


EURASIA PROGRAMME

18-20 October 20174th Masterclass in Clinical Oncology | Tbilisi, Georgia

10-13 November 2018ESO-ASCO Masterclass in Clinical Oncology | Yerevan, Armenia

LATIN AMERICA PROGRAMME

18-22 April 20184th ESO-ESMO Latin American Masterclass in Clinical Oncology | Mexico City, Mexico

WORLD ONCOLOGY FORUM®

19-21 October 2017Stop Cancer Now! Cancer and Global Health: From Research to Policy | Lugano, Switzerland

VISITING PROFESSORSHIP MEETINGS

12-14 October 2017Visiting Professorship Meeting in Gastro-intestinal Cancer | Sarajevo, Bosnia and Herzegovina

2018Visiting Professorship Meeting in Breast Cancer | Pristina, Kosovo

ESO OBSERVATORIES AND SESSIONS

OBSERVATORIES AND S

CAREER DEVELOPMENT

ESMO Preceptorship on Immuno-Oncology

Clinical Training Centres Fellowship Programme

Certificate of Competence in Lymphoma (Fourth cohort 2019-2020)

Certificate of Competence in Breast Cancer (Third cohort 2019-2020)

Master Online Advanced Oncology

Online Master in Molecular Oncology

Online Master in Medical Oncology

International Online Master Degree in Gynaecologic Oncology

MEDIA ACTIVITIES

Cancer World Journalism Award and Cancer World Journalist Network

PUBLICATIONS

Cancer World Magazine

Critical Reviews in Oncology/Hematology (CROH)

The Breast

Nature Reviews Clinical Oncology (NRCO)

Tumori Journal

BREAST CENTRES NETWORK

PROSTATE CANCER UNITS NETWORK

ES

O E

DU

CA

TIO

N 2

017

-20

18


#e_ESO

For further information: Francesca Marangoniwww.e-ESO.net - [email protected]

DISTANCE LEARNING

e-ESO learning platforme-ESO is a platform dedicated to providing distance learningmaterials in the form of:

• E-sessions (live and recorded); • Slides from ESO's events;• Clinical cases.

Materials are divided into categories: • Recorded sessions (past live sessions that have been

recorded and can be viewed online); • Downloadable PDF presentations from past ESO events; • Future sessions (scheduled sessions that will be presented

live on the indicated date - participants can interact with thespeakers during the sessions);

• Clinical cases (provided via ePatCare, see below).

ESO’s live e-sessions are held every week on Thursday at 18:15-19:00 CET. Participants can eitherattend the live session or view the recorded session that is available 24 hours after the live session. e-sessions are CME accredited (except for the sponsored sessions and the sessions recorded at liveevents).Over 500 e-sessions on a variety of subjects have already been delivered to over 8,600 registeredusers from more than 130 countries!

e-ESO is proud of its collaboration with internationally renowned speakers and of the growing number of educational e-learning resources available on its website and openly accessible by all interested health professionals from across theglobe, free of charge.

More than 400 e-learning resources are available on the e-ESO website!www.e-ESO.net

ePatCare®

ePatCare® is a unique educational software tool developed to improve the dialogue between clinicians by providinginteractive training, and to ultimately advance patient care. ePatCare® provides clinicians the opportunity to create, view,share and present their clinical patient cases within the Oncology Community. It focuses on the needs of this specific targetgroup by offering a patient case sharing function via cloud. This interactive and intuitive platform enables users to easilycreate an attractive and appealing patient case that can be presented to an audience. This is what makes this tool trulyvaluable for HCPs.The intuitive handling of the software as well as a chronological, well-structured and comprehensible presentation of patientcases facilitates discussions with other oncologists or tutorials for students. A virtual journey guides the user through thepatient's history from their presentation to investigation, diagnosis, management and outcomes, with all the patient's medicalbackground and test results located in one convenient place. ePatCare® provides you with clinical real-life cases that havebeen seen and managed by oncology specialists.

More than 60 cases available on the ESO ePatCare platform!www.e-ESO.net/epatcare.do

ePatCare is developed by infill Kommunikation and the platform was providedby Boehringer Ingelheim.

e-ESO and ePatCare online resources are available free of charge.

nOfoloohcSnaeporuE

ygolocn

ten.ose-e

acudEruoY

,noita !y!awaakckicliclatsujdnaeerfr

e.www

teGstidercEMC

nraeL-e

slairetamdnastnassucsid,strepxeruohtiw

sseccA

emitynataetisehtnoelbaliavaslairetamyna

ILtcennoC

TEC51:81tayadsruhTno

tcaretnI

snoissesevilehtRETFAdnaGNIRUD,EROFEBstrepxeruootsnoitseuqgniksayb

etaerC

adnegaOSE-enworuoy

SCIPOT• ygolocnOlacideM• ygolocnOlacigruS• ygolocnOnoitaidaR• ygolocnOotameaH• gnisruN

!EROMHCUMDNA

TNETNOC• sthgilhgiH• syawhtaP• setabeD• sdnuordnarG• sweiverocnO• sesaclacinilC• sedilS

IDNANOISSESNE,YY,ADSRUHT

51:9 cnarFnaS51:21 N,notsoB51:41 AsoneuB51:71 iL,nilbuD51:81 P,dirdaM51:91 epaCoriaC

EVI

TCARETNEVILEHTRETN

ocsickroYwe

serinodnoL,nobs

emoR,siravivAleT,nwoTe

desinagroruoY

aivetad-ot-pupeeK OSE_e#

•

htiwnoitaroballocniygolocnOfoloohcSnaeporuEehtybpihsrosnopslaicremmoctuohtiwdnoitacudehtiwstnemtniopparaluger

sedilS 51:91 epaC,oriaC51:02 wocsoM51:12 iabuD54:22 iabmuM

balloc

htiwnoitarob


EASTERN EUROPE AND BALKAN REGION REFRESHER COURSE ON BREAST CANCER

THE APPLICATION DEADLINE HAS PASSEDTHE NEXT REFRESHER COURSE WILL BE HELD IN 2018

6-7 October 2017 - Krakow, PolandChairs: A. Eniu, RO - E. Senkus, PL Host Chair: W. Wysocki, PL

Learning objectives:• Update on the latest advances in diagnostic procedures• Update on the latest advances and on the state-of- the-art

treatment options• Learn about the management of specific situations• Debate controversies and challenges in breast cancer

treatment • Improve practical skills in multidisciplinary managementand follow-up of breast cancer patients

• Receive insights on the best approaches in organizing breastcancer care (breast cancer units)

Main topics:• Update on standard and new diagnostic, treatment options and

approaches • Signalling pathways • Breast cancer pathology and molecular biology• Systemic treatment of early and advanced breast cancer

Participant’s profile:• Participants of the previous Eastern Europe and Balkan Region

Masterclass in Clinical/Medical Oncology or further partici-pants with the following profile:

• Age between 30 and 45 years• At least 2-3 years’ experience in medical oncology• Fluency in English• Practicing in Eastern Europe and Balkan Region• Priority will be given to applicants who have attended a

previous Eastern Europe and Balkan Region Masterclass• Each past participant will be able to invite one colleague to join

the course, and further interested medical/clinical oncologistswill be able to apply too

Further information:Laura Richetti, [email protected], ph +41 91 8200951

The Refresher Course on Breast Cancer has been designedfor medical and clinical oncologists who have attended aprevious edition of the Eastern Europe and Balkan Region

Masterclass in Medical/Clinical Oncology and other practicingoncologists of the region with the aim to provide an update onthe state-of-the-art therapeutic options as well as an overview ofthe latest advances in the field of breast cancer.The programme will offer educational lectures covering updates

on the diagnosis and treatment of both early and advancedbreast cancer.Moreover, spotlight lectures will discuss specific issues relatedto particular situations such as breast cancer in young women orsurvivorship issues.Practical training will be offered in the frame of clinical case presentations, prepared and presented by participants and discussed with the faculty with interactive voting.


Learning objectives:• Update the knowledge on basic science of clinical and medical

oncology• Improve medical oncologists’ skills• Practicing case discussion• Deep focus on lung, head and neck, genitourinary,

gynaecological and breast cancers• Compact update on further topics of interest

Main topics:• Lung cancer• Head and neck cancer• Genito-urinary cancer• Gynaecological cancers• Breast cancer

Participant’s profile:• Age up to 40 years• At least 2-3 years’ experience in medical or clinical oncology• Involvement in scientific activities • Fluency in English• Practicing in the Eurasian Region

Further information:Daniela Mengato, [email protected], ph +39 02 85464523Alice Ciocchini, [email protected], ph +39 02 85464529

This residential programme has mainly been designed foryoung medical, radiation and clinical oncologists, whowish to improve their skills. The programme will expose

participants to a full spectrum of issues in clinical and medicaloncology from basic science to advanced knowledge of systemic therapy as well as in the multidisciplinary treatment approach. The programme focuses on frequent cancers such aslung, head and neck, genito-urinary, gynaecological and breast.

Spotlight sessions will provide an insight on the state-of-the-artapproaches in melanoma, cervical cancer and cancer in pregnancy. Furthermore, practical training will be offered in theframe of clinical case presentations, prepared and presented bythe participants and interactively discussed by the faculty members. All participants will reside at the Masterclass venueand participation is mandatory throughout the course.

4TH MASTERCLASS IN CLINICAL ONCOLOGY

BY APPLICATION ONLYTHE APPLICATION DEADLINE HAS PASSED

18-20 October 2017 - Tbilisi, GeorgiaChairs: N. Pavlidis, GR - D.G. Zaridze, RU

Host Chair: R. Gvamichava, GE

Stop Cancer Now!Cancer and Global Health:From Research to Policy19-21 October 2017 Lugano, SwitzerlandChair: Franco Cavalli

Scientific Committee: Alexander M.M. Eggermont Mary Gospodarowicz You-Lin QiaoRichard Sullivan Edward Trimble Chris Wild Paul Workman

£5.00 Registered as a newspaper · ISSN 0140-6736Founded 1823 · Published weekly

“More deaths occur worldwide from breast and cervical cancer than from maternal mortality.”

See Articles page 1461

www.thelancet.comVolume 378 · Number 9801 · Pages 1439–1526 · October 22–28, 2011

Comment

What global protection against women’s cancers?See page 1442

Articles

Breast and cervical cancer in 187 countries between 1980 and 2010See page 1461

Articles

Primary care referral to a commercial provider for weight loss treatment versus standard careSee page 1485

Articles

China’s facility-based birth strategy and neonatal mortalitySee page 1493

Series

Global Mental Health 1 and 2: Poverty and mental disorders; Child and adolescent mental health worldwideSee pages 1502 and 1515

In collaboration with:

Editorial partner:

Further information available at: www.eso.net

Held with the support of


Learning objectives:• Update on the most important advances in the field of

gastrointestinal malignancies (including liver), breast cancer,gynecological malignancies, lung cancer etc.

• Improve the skills and knowledge on practical clinical issues,such as management of common treatment-related toxicities,patients with cancer emergencies, specific problems with targeted therapies, new strategies in advanced skin, lung, gastro-intestinal and breast malignancies.

Main topics:• Gastro-intestinal malignancies (including liver)• Lung cancer• Early and advanced breast cancer • Melanoma and other skin malignancies• Gynecological malignancies• Treatment-related toxicities

Participant’s profile:• Medical oncologists, radiation oncologists and surgical

oncologists• Other medical specialties involved in cancer care

(e.g. radiologists, pathologists, general practitioners, etc.)• Medical students and nurses

Further information:Medycyna Praktyczna - Conferences Liszki, PolandMichał Bańdo, [email protected], ph +48 12 2934279

The refreshed format of the 2017 conference enhanceslearning opportunities for participants. The new featuresincludespecial sessions designed for in-training

oncologists with question-and-answer modules and simulatedboard certification tests in oncology that will be discussed indepth to improve the participants’ learning experience. The Conference offers plenary lectures delivered by the leadingexperts in the field, focusing on the state-of-the-art therapiesand concluding with take-home messages. Lectures will coverthe current standards of modern oncology, with special attentionto practical aspects of effective cancer treatment.Multidisciplinary interactive sessions will be opened also for

non-oncologists dealing with cancer patients (radiologists,pathologists, GPs etc.).Leading European experts, invited jointly by ESO and MedycynaPraktyczna - Onkologia, will deliver lectures on practical clinicalissues, such as management of patients with gastrointestinalmalignancies (including liver), current strategies in gynecologicaloncology and advanced lung cancer, management of breastcancer (including novel therapeutic options), treatment of renal,bladder and prostate cancer, basic maneuvers in advanced malignancies, skin malignancies, oncological emergencies etc.The Conference will be held in English and in other languages,for which simultaneous translation in English will be provided.

9TH CLINICAL ONCOLOGY UPDATE ONKOLOGIA 2017

DEADLINELATE REGISTRATION: 15 OCTOBER 2017

28 October 2017 - Krakow, Poland Scientific Coordinator: W.M. Wysocki, PL


ADVANCED BREAST CANCER FOURTH ESO-ESMO INTERNATIONAL CONSENSUS CONFERENCE (ABC4)

DEADLINESLATE REGISTRATION: 15 OCTOBER 2017

ON-SITE REGISTRATION: FROM 16 OCTOBER 2017

2-4 November 2017 - Lisbon, PortugalCoordinating Chair: F. Cardoso, PT - Chairs: E.P. Winer, US - L. Norton, US - A. Costa, IT/CHCo-chairs: E. Senkus, PL - E. Papadopoulos, CY - Scientific Committee: M.S. Aapro, CH - F. André, FR - N. Harbeck, DE

Consensus and cooperations:ABC guidelines are jointly developed by ESO and ESMO and simultaneously published in The Breast and Annals of Oncology.Furthermore, ABC guidelines or conferences have been endorsed and supported by several other international oncologyorganizations such as EUSOMA, ESTRO, ESGO, UICC, SIS/ISS,FLAM, OECI, Susan G. Komen and BCRF, and has official representation from ASCO.

Main topics:• Optimal management of Luminal ABC: endocrine resistance, new

therapies, best sequencing of agents• Optimal management of HER-2-positive ABC: resistance to

anti-HER2 therapies, new agents, role of biosimilars• Optimal management of triple negative ABC: new agents, role of

immunotherapy• Affordability and access to care. Assessment of value.• Use of multigene sequencing and liquid biopsies• Legal issues: loss of insurance coverage, loss of job, adoption• Maintenance treatment• Metronomic chemotherapy• Special populations: management of ABC in elderly patients• Specific sites of metastases: malignant ascitis and peritoneal

carcinomatosis• Side effects: neurotoxicity• The programme will also include patient advocacy sessions

developed in cooperation with several leading breast cancer patient advocacy groups worldwide.

Participant’s profile:• Health professionals, representatives of breast cancer

advocacy groups and media are cordially invited to participate inthe ABC Conference and its consensus session.

Further information:Please subscribe to the ABC website at www.abc-lisbon.org andreceive updates automatically.

ABC has established itself as a major international breast cancerconference. Its primary aim is the development of international consensus guidelines for the management of advanced breast

cancer patients. These treatment guidelines are based on the mostup-to-date evidence and can be used and adapted to many differenthealth care settings globally. The last meeting held in November2015 brought together over 1200 participants from 84 countriesaround the world, including health professionals, patient advocatesand journalists. ABC has the ambitious goal of improving outcomesfor all patients with advanced breast cancer. We believe that healthprofessionals working closely together with patient advocates and

with the strong support of media can raise awareness about the needs and challenges faced by this traditionally underserved and forgotten group of patients.We aim to identify research priorities based on the most importantareas of unmet need, analyse and discuss available data to providethe most accurate management recommendations, but also to influence policy makers and funding bodies and ultimately improvestandards of care, survival and quality of life. Research and education, with accurate usage of available knowledge, throughoutthe world, are key to achieve these goals.

Improving and extending the livesof women and men living withadvanced breast cancer (ABC) in all countries worldwide

The ABC Global Alliance is a multi-stakeholder platformfor all those interested in collaborating

in common projects relating to advanced breast cancer (ABC).

The ABC Global Alliance is an ESO initiative also sponsored through unrestricted grants provided by:

Main sponsors:

Sponsor:

@[email protected]


2ND ESO-ESMO-RCE CLINICAL UPDATE ON RARE ADULT SOLID CANCERS

DEADLINESTRAVEL GRANT APPLICATION: 1 OCTOBER 2017

EARLY REGISTRATION: 31 OCTOBER 2017

2-4 December 2017 - Milan, ItalyChairs: J.Y. Blay, FR - P.G. Casali, IT - R.A. Stahel, CH

Held in collaboration with

Learning objective:• Update on latest clinical development on rare cancers with a

background perspective on the state-of-the-art therapeutic approaches

Main topics:• Patient empowerment in rare cancers• Rare skin cancers and non-cutaneous melanoma• Rare thoracic tumors• Rare female genital cancers• Neuroendocrine tumours• Endocrine gland tumours• Sarcomas• Digestive rare cancers• Rare urological and male genital tumours• Central nervous system neoplasms• Head and neck cancers

Participant’s profile:• Degree of specialization in medical oncology, radiation

oncology, surgical oncology or equivalent

Further information:Marina Fregonese, [email protected], ph +39 02 23902106

• The 3rd edition will be held in November/December 2018

Rare cancers make up as many as one fifth of all new cancer cases. Paediatric cancers and rare haematologicneoplasms are often covered by dedicated educational

events while rare adult solid cancers are hardly grouped together as a collective group of neoplasms. This course isaimed at dealing with them on an annual basis to provide thecommunity of clinical oncologists specialising in these tumorswith a regular update of recent advances in this specific area.

The ultimate goal is to strengthen the educational coverage of agroup of cancers which may be neglected in spite of their collective incidence. This year we are amid the process of cre-ation of the new European Reference Network (ERN) includingrare adult solid cancers, with the ERN named EURACAN. Manyspeakers and moderators will come from EURACAN. The coursewill be an opportunity to consolidate the network of oncologistsworking within it or in collaboration with it.

In addition, Rare Cancers Europe, in collaboration with ESO, will organize a PilotTraining Course for Rare Cancer Patient Advocates, which will run in parallel.For information about this event, please visit http://rarecancerseurope.org



UNIVERSITY POST-GRADUATE COURSES IN CLINICAL ONCOLOGY OF RARE ADULT SOLID CANCERS

APPLICATION DEADLINES TO BE ANNOUNCED

University of Milan, Italy

Participant’s profile:• Medical degree• Current involvement in clinical activities in the oncology area

(with preference to rare cancers)

Main topics:• Natural history, biology, epidemiology, imaging and pathology

of head and neck cancers• Clinical Management of: Oral cavity and oropharyngeal cancers;

Larynx and hypopharynx cancers; Nasopharyngeal andparanasal cancers; Salivary glands

• Clinical cases discussion and issues in head and neck cancers

Further information:Marina Fregonese, [email protected], ph +39 02 239 02106Updated information available at www.eso.net.

The University of Milan, Italy, in close collaboration with ESOwill launch a programme of post-graduate courses on rareadult solid cancers. Each of them will last one week (30

hours) and will focus on one of the ten “families” of rare adultsolid cancers. This programme is addressed to an internationalaudience of clinical oncologists interested in advancing theirknowledge and skills on one or more adult solid cancers.Courses will be highly multidisciplinary, held in English and begrant European and Italian CME credits. Both ESO and the

University of Milan are involved as associated partners in thenew established EURACAN, the European Reference Network onrare adult solid cancers. Thus, this educational effort is addressed to reinforce the collaboration among oncologists ofdifferent countries already involved in EURACAN, or in networksrelated to EURACAN, or willing to be part of it in the future. Admission to the course will be by competitive application only.Attendance is limited to 30 participants. Two courses have beenalready scheduled at the beginning of 2018.

CLINICAL ONCOLOGY: HEAD & NECK CANCERS5-9 February 2018 - University of Milan, ItalyScientific Coordinator: L. Licitra, IT

CLINICAL ONCOLOGY: SARCOMAS22-26 January 2018 - University of Milan, ItalyScientific Coordinator: P.G. Casali, IT

Main topics:• Natural history, epidemiology and pathology of sarcomas• Clinical Management of soft tissue sarcomas, bone sarcomas

and GIST• Clinical cases discussion


6TH ARAB AND SOUTHERN EUROPEAN COUNTRIES MASTERCLASS IN CLINICAL ONCOLOGY

BY APPLICATION ONLYTHE APPLICATION DEADLINE HAS PASSED

15-18 December 2017 - Limassol, CyprusChairs: M. Aapro, CH - N. Pavlidis, GRCo-chairs: J. Gligorov, FR - S. Khatib, JO - Host Chair: D. Papamichael, CY

Learning objectives:• Improve medical and radiation oncologists’ skills• Practicing case discussion• Deep focus on breast, gynaecological, prostate, lung and col-

orectal cancer, lymphomas

Main topics:• Breast cancer• Gynaecological cancer• Lung cancer• Urological cancer• Gastrointestinal cancer• Lymphomas

Participant’s profile:• Age up to 40 years• At least 2-3 years’ experience in the field (medical /clin-

ical oncology) • At least an intermediate level of English• Involvement in scientific activities (desirable)• Practicing in the region

Further information:Daniela Mengato, [email protected], ph +39 02 85464523

This is a three-days clinically oriented educational programme dedicated to medical, clinical and radiationoncologists, who wish to improve their skills in oncology.

The programme focuses on breast, gynaecological, prostate, colorectal, lung cancers and on lymphomas and its covered byan international faculty of top experts.The Masterclass offers:• plenary lectures regarding state-of-the art clinical evaluation

and treatments with reference to clinical guidelines concludingin take-home messages;

• clinical case presentations will be delivered by the participantsin Tumor Board discussions as well as in divided small groupswith the presence of the chairmen and the faculty;

• a self-assessment test based on multiple choice questionnaire,will be provided to participants on the last day of the Masterclass.

All participants will reside at the course venue and participationis compulsory throughout the course. The Masterclass will beheld in English and fluency in English is necessary for admission.

Held in collaboration with Held under the auspices of


3RD ESO MASTERCLASS IN CANCER PATIENT ADVOCACY

ATTENDANCE IS BY INVITATION ONLYATTENDEES WILL BE NOMINATED BY ORGANISATIONS

23-25 February 2018 - Lisbon, PortugalScientific Co-ordinator: K. Redmond, CH

Steering Committee: V. Astratinei, RO - K. Benn, IT - F. Florindi, BE - J. Geissler, DE - G. Henning, UK - T. Kolarova, BG K. Mastris, UK - K. Oliver, UK - A. Plate, DE - C. Roffiaen, IT - J. Taylor, UK - A. Stunt, UK - S. Wintrich, UK

Learning objectives:• Help participants hone their advocacy and leadership skills • Discuss ways of improving organizational impact and

effectiveness• Review state-of-the-art approaches to evidence based

advocacy• Provide participants with the opportunity to network and share

experiences

Main topics:• Lobbying for change• Building effective and sustainable EU cancer patient networks

(leadership, effectiveness, challenges of working with industry,Boards)

• Achieving sustainable access to cancer therapies• Developing advocacy leadership skills (Communication, Per-

suasion & Influence, Coaching, Interpreting scientific data)• Moving from anecdotal to evidence based advocacy

Participant’s profile:• Highly experienced cancer patient advocates who are involved

in one of the European cancer patient networks• Future leaders of European cancer patient advocacy groups • Fluency in English

Further information:Corinne Hall, [email protected], ph +39 02 85464522

The Masterclass in Cancer Patient Advocacy was launchedby the European School of Oncology in 2014 to meet theeducational needs of highly experienced cancer patient

advocacy leaders who have limited opportunities to developtheir advocacy skills, get updated on key cancer policy issuesand explore how to improve their organisation’s performance.This third edition of the Masterclass will bring together seniorrepresentatives of European and international cancer patient

networks as well as a small number of future leaders. To ensure that the Masterclass meets the needs of senior Euro-pean cancer patient leaders, ESO has established a steeringcommittee consisting of representatives from a number of theEuropean cancer patient networks. Selected EU/international cancer patient networks will be in-vited to send two delegates to the Masterclass (in addition totheir representative on the Steering Committee).

The European School of Oncology is grateful to the following companies for supporting the Masterclass:

AstraZeneca, Helsinn, Lilly, Merck KGaA, Darmstadt, Germany, Novartis, Pfizer, Roche

The Masterclass will be held in collaboration with the following cancer patient organisations:

International Brain Tumour Alliance (IBTA), Europa Uomo, CML Advocates,Myeloma Patients Europe (MPE), Pancreatic Cancer Europe/World Pancreatic Cancer Coalition, Europa Donna, International NeuroendocrineCancer Alliance (INCA), European Cancer Patient Coalition (ECPC), EuropaColon, Melanoma Patient Network Europe, MPNE Ocular/Rare MelanomaGroup, Sarcoma Patients Euronet, International Kidney Cancer Coalition EURORDIS, MDS Alliance, Lung Cancer Europe (LUCE), Lymphoma Coalition Europe, Thyroid Cancer Alliance


17TH ESO-ESMO MASTERCLASS IN CLINICAL ONCOLOGY

DEADLINEBY APPLICATION ONLY: 1 DECEMBER 2017

24-29 March 2018 - Nauen OT Groß Behnitz (Berlin), GermanyChairs: N. Pavlidis, GR - R. Stahel, CH Scientific Advisors: F. Lordick, DE - R. Popescu, CH

Learning objectives:• Improve medical oncologists’ skills• Help in preparing for the national board exam• Practicing case discussion• Deep focus on breast, gastro-intestinal, genitourinary, gynaeco-

logical, head and neck and lung cancers• Compact update on communication skills, mind boy medicine,

molecular tumour boards, gender issues, melanoma and im-munotherapy, immune-oncology, magnitude of benefits scale,sarcomas and GIST, adolescents and young adults, low nadhigh grade lymphomas, supportive and palliative care, man-agement of elderly cancer patients, biosimilars and drug repo-sitioning, ethical dilemmas

Main topics:• Breast cancer • Gastro-intestinal tumours • Genito-urinary cancers • Gynaecological cancers• Head and neck cancer• Lung cancer

Participant’s profile:• Age between 30 and 40 years• At least 2-3 years’ experience in medical oncology or clinical

oncology• Involvement in scientific activities• Fluency in English

Further information:Francesca Marangoni, [email protected], ph +39 02 85464525Corinne Hall, [email protected], ph +39 02 85464522

The Masterclass offers plenary lectures discussing currentissues and controversies as well as critically reviewing significant therapeutic developments. State-of-the-art

data recognized by ESMO and other evidence-based guidelineswill be citedParticipants will deliver case presentations within tumour boards and small groups and discuss them with thechairs and the faculty. Informal discussion will be facilitated

during the aperitifs with the expert. All participants will reside at the course venue and participationis compulsory throughout the course. The Masterclass will beentirely in English and fluency in English is necessary for admission. Participants of the concomitant Masterclass in Nursing Oncology will attend selected medical sessions whilstthe communication skills sessions will be attended jointly.

Held in collaboration with Part of the Master Online Advanced Oncology of


11TH ESO-EONS MASTERCLASS IN ONCOLOGY NURSING

DEADLINEBY APPLICATION ONLY: 1 DECEMBER 2017

24-29 March 2018 - Nauen OT Groß Behnitz (Berlin), GermanyChairs: C. Lacerda, PT - E. van Muilekom, NL

Coordinator: R. Verity, UK - Advisor: B. Grube, DK

Learning objectives:• Understand new developments in oncology disease

management• Recognize and describe acute and late adverse effects of

cancer and its treatment• Identify complex patient needs across the cancer trajectory• Demonstrate understanding of advanced communication skills

in oncology nursing care• Critically appraise the evidence for cancer symptom

management and care interventions• Reflect on theoretical underpinnings of decision making• Describe the role of the advanced oncology nurse in leading

clinical nursing care

Main topics:• Medical management, treatment options • Effective symptom management and care interventions• Understanding evidence based knowledge• Newer areas of oncology nursing• Improving patient experience and outcomes

Participant’s profile:• Person working at an advanced nursing practice level, and with at

least 3-5 years of clinical cancer nursing practice (a Master of Nursing Science degree is not mandatory)

• Person involved in direct patient care, also combined with the management, organisations and co-ordination of cancer patient care

• Fluent in English (reading and speaking)• Member of an EONS member society or individual member of EONS• Participants will be selected by means of a strict application review

Further information:European Oncology Nursing Society, EONS SecretariatBrussels, BelgiumRudi Brike, [email protected], ph +32 2 7799923

The Masterclass in Oncology Nursing programme is designed for European advanced cancer nurses as a multi-professional joint event. Five intensive days of full

immersion in up-to-date oncology will create a collective spirit ofteaching and learning to improving clinical skills and patientcare. Nursing sessions are specific nursing-oriented sessions exploring specialist practice skills such as assessment and decision making, communication skills, complex symptom management, research in nursing, psychosocial consequencesof cancer therapy to mention a few. Other sessions will providethe forum for reviewing and understanding the growing

evidence base for nursing interventions and reflect on participant’s role in clinical leadership. Case studies will be presented by the participants and will explore nursing practicefocusing on special aspects of care. In joint clinical sessions,nurses will, together with physicians, update their clinical knowledge about the latest issues for the management of various cancers, with an international faculty of experts. Specialjoint sessions will highlight and support the growing need formultiprofessionality in chosen topics. Practical training will be offered in smaller group sessions, case study sessions focusingon skills necessary for patient care management.


4TH ESO-ESMO LATIN AMERICAN MASTERCLASS IN CLINICAL ONCOLOGY

DEADLINEBY APPLICATION ONLY: 14 JANUARY 2018

18-22 April 2018 - Mexico City, MexicoChairs: A. Cervantes, ES - N. Pavlidis, GR - R.A. Stahel, CHScientific Coordinators: M. Aapro, CH - F. Cardoso, PT

Learning objectives:• Improve medical oncologists’ skills• Practicing case discussion• Deep focus on breast, gastro-intestinal, genitourinary,

gynaecological, head and neck and lung cancers • Compact update on further topics of interest

Main topics:• Breast cancer• Gastro-intestinal cancers• Genito-urinary cancers• Gynaecological cancers• Head and neck cancer• Lung cancer

Participant’s profile:• Age between 30 and 40 years• At least 3 years’ experience in medical oncology

(or clinical oncology)• Involvement in scientific activities (desirable)• Intermediate level of English language• Practicing in Latin America

Further information:Luis Carvalho, [email protected], ph +41 91 8200958Alice Ciocchini, [email protected], ph +39 02 85464529

The Masterclass is the most structured ESO educational activity whose format has been established and presentedin Europe for over a decade. The success of the teaching

method has been confirmed by the events held also in otherparts of the world as well as by the three editions held in LatinAmerica. It is with pleasure and gratefulness for the consideration of the local community, that ESO announces thefourth edition to be held in the region in 2018. The Masterclass offers plenary lectures discussing current

issues and controversies as well as critically reviewing significanttherapeutic developments. State-of-the-art data recognized byESMO and other evidence-based guidelines will be cited. Participants will deliver case presentations within tumour boardsand small groups and discuss them with the chairs and the faculty. As for all Masterclasses, the number of participants willbe limited and admission will be by competitive application only.Admitted participants will be granted free registration and half-board accommodation for the duration of the Masterclass.

Held under the auspices of


8TH ESO-CNIO FAMILIAL CANCER CONFERENCE

DEADLINES ABSTRACTS SUBMISSION: 4 MARCH 2018

EARLY REGISTRATION: 31 MARCH 2018LATE REGISTRATION: 30 APRIL 2018

17-18 May 2018 - Madrid, SpainChairs: R. Eeles, UK - W. Foulkes, CA - M. Robledo, ES - H. Vasen, NL

Learning objectives:• Improve the understanding of the selection criteria the

landscape of breast and ovarian cancer genes, and their clinicalimpact

• Update the knowledge about genetics and clinical management of hereditary colorectal cancer

• Appraise herapeutic strategies in the era of personalized medicine and implications of applying next generation sequencing to the diagnosis

• Learn about translating genetic risk factors to the surveillanceand clinical management of prostate cancer

• Update the knowledge about rare cancers: new genes, newapproaches, new challenges.

Main topics:• Breast and ovarian cancer• Colon and prostate cancer• Rare cancers• Implications of applying next generation sequencing to the

diagnosis

Further information:Luis Carvalho, [email protected], ph +41 91 820 0958Daniela Mengato [email protected], ph +39 02 854 64523

The ESO and CNIO Conference on Familial Cancer aims topresent the advances in this field from a multidisciplinarypoint of view. Due to its implications not only at individual

but also at the familial and social level, familial cancer has become an important challenge for oncologists, geneticists, molecular biologists and other professionals.. Along the lastyears, new approaches have allowed to increase our knowledgeabout the genes responsible for familial cancer as well as theirbiological functions – factors that are essential in identifying theappropriate treatment in each case. The next generation sequencing is extensively used in the search of causal mutationsbut it represents a new challenge regarding the interpretation of

variants, many of which must be classified as of unknown significance. Biannually the Conference brings together leading basic andtranslational researchers and clinicians involved in the diagnosis,treatment and follow-up of patients with familial cancer. Thesemeetings help to establish connections among professionalsthat in turn promote progress in the understanding and treatment of these diseases. Besides the lectures from international experts, young scientists can present their work asshort lectures and posters. This format aims to facilitate extensive discussion of current issues and stimulate new ideas.


3RD MASTERCLASS ON SYSTEMATIC REVIEWS IN CANCER CARE, GUIDELINES AND RESEARCH

DEADLINEBY APPLICATION ONLY: 11 FEBRUARY 2018

18-22 May 2018 - Belfast, United KingdomChair: M. Clarke, UK

Learning objectives:• Formulation of the question• Choice of inclusion and exclusion criteria, and selection of

outcomes• Development and implementation of a search strategy• Application of the inclusion and exclusion criteria, and appraisal

of quality and risk of bias in potentially eligible studies• Data extraction• Planning and conduct of meta-analyses, including subgroup

and sensitivity analyses• Exploration of heterogeneity• Drawing conclusions and discussing implications for practice

and research

Main topics:• Question formulation for systematic reviews • Eligibility criteria and outcome selection • Search strategy • Study quality and risk of bias• Statistical analysis and heterogeneity• Implications for practice and research

Participant’s profile:• Healthcare practitioners with at least two years’ experience in

the provision of care to cancer patients• Familiarity with research into the effects of interventions for

cancer patients, including randomized trials • Basic understanding of the role of systematic reviews

as a source of knowledge for decision making• Fluency in English

Further information:Francesca Marangoni, [email protected], ph +39 02 85464525

This five-day course will take participants through the keysteps in preparing a systematic review of research in cancer that they can use to make decisions about

treatment, guidelines or the design of new research. Each participant will bring a topic for a systematic review to the Masterclass, and this will form the basis of the problem-basedlearning approach that will be used throughout the course. Each day of the Masterclass will include formal lectures from experts in the relevant topic area, as well as group discussions

relating to that topic area, drawing on the knowledge of the expert. The group discussions will be a mixture of whole-groupwork, and smaller discussions in which participants will work insmall parallel groups to tackle specific issues relating to their review questions. These small group sessions will conclude witha plenary session in which one member of each small group willprovide feedback to all the participants on specific issues discussed about the reviews in their small group.



SIOPSIOP Europethe European Society for Paediatric Oncology

7TH ESO-SIOP EUROPE MASTERCLASS IN PAEDIATRIC ONCOLOGY

DEADLINEBY APPLICATION ONLY: 12 FEBRUARY 2018

16-21 June 2018 - Nauen OT Groß Behnitz (Berlin), GermanyChairs: S. Bielack, DE - A. Eggert, DE - B. Morland, UK - R. Riccardi, IT

Learning objectives:• Receive qualified training in paediatric oncology to improve

knowledge of the main topics listed below• Improve skills in dealing with cancer problems as a whole• Improve knowledge of current clinical practice and state of the

art treatment• Improve doctor-patient communication as well as >

doctor-parent communication

Main topics:• Central nervous system tumours• Neuroblastoma• Soft-tissue sarcoma• Bone tumours• Wilms’ tumour• Rare tumours

Participant’s profile:• Age between 30 and 40 years• 2-4 years’ experience in paediatric oncology• Involvement in scientific activities and clinical trials• Fluency in English

Further information:Alice Ciocchini, [email protected], ph +39 02 854 64 529Alexandra Zampetti, [email protected], ph +41 91 8200954

ESO and SIOP Europe are pleased to announce the seventhMasterclass in Paediatric Oncology. This clinically-orientededucational programme has been designed for young

paediatric oncologists who wish to improve their skills in clinicalmanagement of common childhood tumours. It is designed tooffer a unique learning experience, providing practice-oriented

training and the teaching sessions will focus on the application ofthe most recent research findings to clinical practice. Practicaltraining will be offered in the frame of clinical case presentations,prepared and presented by the participants for an interactive discussion. All participants will reside at the Masterclass venueand participation is mandatory throughout the course.


5TH ESO-ESMO EASTERN EUROPE AND BALKAN REGION MASTERCLASS IN MEDICAL ONCOLOGY

DEADLINEBY APPLICATION ONLY: 2 APRIL 2018

Dates to be announced - Belgrade, Republic of SerbiaChairs: A. Eniu, RO - N. Pavlidis, GR - C. Zielinski, AT

Learning objectives:• Update the knowledge on basic science of clinical and

medical Oncology• Enhance the competence and practical performance in

systemic therapy of malignancies• Enhance the competence and practical performance in

multidisciplinary cancer care• Update knowledge and get additional skills in supportive as

well as palliative care• Prepare for the board exam in clinical/medical oncology

Main topics:• Cancer biology/pathology• Cancer genetics• Pharmacology of anti-cancer drugs• Breast cancer• Gastro-intestinal tumours• Lung cancer and mesothelioma• Genito-urinary cancers• Palliative and supportive care• Lymphoma malignancies

Participant’s profile:• Age between 30 and 40 years• 2-4 years’ experience in oncology• Involvement in scientific activities and clinical trials• Fluency in English• Practicing in Eastern Europe and Balkan Region

Further information:Dolores Knupfer, [email protected], ph +41 91 8200952Laura Richetti, [email protected], ph +41 91 8200951

The Masterclass offers plenary lectures discussing currentissues and controversies as well as critically reviewing significant therapeutic developments. State-of-the-art

data recognized by ESMO and other evidence-based guidelineswill be cited. The programme has been designed for youngmedical and clinical oncologists, who wish to improve their skillsor those who are preparing for the national board or ESMO exam.The programme will expose participants to a full spectrum of issues in clinical and medical oncology from basic science to advanced knowledge of systemic therapy as well as in the

multidisciplinary treatment approach. It is intended to cover allmajor topics of ESMO-ASCO curriculum on medical oncology.Participants will deliver case presentations within tumour boardsand small groups and discuss them with the chairs and the faculty. Admitted participants will be granted free accommodation and reside at the course venue. Participation iscompulsory throughout the course. The Masterclass will be held in English and fluency in English is necessary for admission.


ESMO-ESO COURSE ON MEDICAL ONCOLOGY FOR MEDICAL STUDENTS

DEADLINEBY APPLICATION ONLY: 15 APRIL 2018

19-24 July 2018 - Valencia, Spain

Learning objectives:• Increase knowledge in medical oncology, filling the gap in the

medical student’s curriculum• Acquire the skills to discuss clinical cases with a

multidisciplinary approach• Enhance and broaden medical education and learning

experience

Main topics:• A practical approach to cancer diagnosis, staging, prognosis

and therapy• Principles of medical therapy for cancer• Breast cancer• Colorectal cancer• Gastric cancer• Ovarian cancer• Lung cancer• Melanoma• Prostate cancer• Renal cell carcinoma• Testicular cancer

Participant’s profile:• Fourth and fifth year medical students• Fluency in English

Further information:European Society for Medical OncologyLugano, Switzerland Doris Vola, [email protected], ph +41 91 9731903

The ESMO-ESO five-day residential course is open to fourthand fifth-year medical students and will focus on medicaloncology. The course will provide an insight into all as-

pects of medical oncology, enabling students to get a full pic-ture of this challenging and interesting professional field before

making the choice of their specialization. The condensed high-standard educational programme aims tomotivate medical students to choose medical oncology as a career.

Held in cooperation with


ESO-ESSO-ESTRO MULTIDISCIPLINARY COURSE IN ONCOLOGY FOR MEDICAL STUDENTS

DEADLINEBY APPLICATION ONLY: 11 MAY 2018

End of August 2018 (dates to be announced) - Poznan, PolandEducational Committee: N. Pavlidis, GR - R. Poetter, AT - S. Sandrucci, IT - J.B. Vermorken, BELocal Organiser: R. Madry, PL - J. Markowska, PL

Learning objectives:• Have a comprehensive understanding of all aspects of

oncology • Have an understanding of the complexity and importance of

the multidisciplinary approach to cancer treatment • Prepare a specific topic related to the theoretical and/or

practical sessions and present it to plenary audience

Participant’s profile:• Fourth year medical students • Fluency in English

Further information:Dolores Knupfer, [email protected], ph +41 91 820 0952

ESO (European School of Oncology), ESSO (European Society of Surgical Oncology) and ESTRO (European Society for Radiotherapy and Oncology) are pleased to

announce the jointly organised multidisciplinary course in oncology for medical students. The key goal of this course is encouraging medical students to specialize in an oncology re-lated discipline. Previous editions organized by ECCO (EuropeanCancer Organisation) since 2005 got very positive and enthusiastic feedback from the students who had spent twoweeks over summer with experienced teachers to receive

theoretical and practical training in cancer care. The multidisciplinary course in oncology will provide insight into allaspects of oncology with both theoretical and practical sessions. The programme incorporates plenary sessions, casestudy presentations, daily special visits to various oncology departments and group course projects that must be finalizedand presented at the end of the course. The course has beendesignated for European Credit Transfer and Accumulation System Credits (ECTS).


Cooperation for promotionprovided by

Main topics:• History, epidemiology, genetics, diagnostics, treatment

principles and therapeutic approaches, prevention and screening

• Communication with the patient• Breast cancer• Colorectal cancer• Gastro-intestinal cancers• Genito-urinary cancers• Gynaecological cancers• Head and neck cancer• Lung cancer• Sarcoma and melanoma

ESO EDUCATION 2017-2018| 25

1ST ESO-EONS EASTERN EUROPE AND BALKAN REGION MASTERCLASS IN ONCOLOGY NURSING

DEADLINEBY APPLICATION ONLY: 31 MAY 2018

20-22 September 2018 - Budapest, HungaryChairs: A. Eniu, RO - B. Grube, DK - L. Sharp, SE

Learning objectives:• Understand new developments in cancer disease management• Recognize and describe acute and late adverse effects of

cancer and its treatment• Identify complex patient needs across the cancer trajectory• Describe the role of the advanced oncology nurse in leading

clinical nursing care

Main topics:• Cancer and lifestyle• Radiotherapy, • Emergency oncology• Supportive and palliative care• Team communication and safety• Chemotherapy, targeted and immunotherapy• Psychosocial issues• Compassion fatigue• Clinical leadership• Case discussion on above topics

Participant’s profile:• 5-10 years’ experience in cancer nursing

Further information:Dolores Knupfer, [email protected], ph +41 91 820 0952Laura Richetti, [email protected], ph +41 91 820 0951

This Masterclass in Oncology Nursing is specifically designed to meet the educational needs of cancer nursesfrom Eastern Europe and Balkan region and, to facilitate

the interaction, simultaneous translation in regional languageswill be provided. Three intensive days of full immersion in up-to-date cancer nursing will create a collective spirit of teaching and learning toimproving clinical skills and patient care. The sessions will provide specialist knowledge on the main topics that will be addressed in the Masterclass either in plenary

or during small group sessions. The number of participants will be limited and admission will beby competitive application only. Admitted participants will begranted free registration and full-board accommodation for theduration of the Masterclass. An amount of maximum 250 Eurowill be available as a contribution for travel support to participants not coming from the Budapest area. All participantswill reside at the course venue and participation is compulsorythroughout the course.


UPDATE SKILLS IN HEAD AND NECK SURGERYAND ONCOLOGY

DEADLINEREGISTRATION: 1 SEPTEMBER 2018

27-29 September 2018 - Leipzig, GermanyCourse Director: A. Dietz, DEOrganising Committee: S. Wiegand, DE - G. Wichmann, DE - C. Standke, DE - R. Wyrwas, DE - J. Leupold, DE

Learning objectives:• Update knowledge on evidence-based modern head and neck

oncology• Improve skills through life surgery and interdisciplinary

discussions

Main topics:• Head and neck surgery• Neck dissection• Reconstructive surgery• TLM, TORS• Multimodality treatment• Chemotherapy• Immuno-oncology• Adjuvant post-operative treatment• Organ preservation

Participant’s profile:• ENT, head and neck surgeons• Clinical and medical oncologists• Radiologists• Phoniatricians• Pathologists• Radiation oncologists

Further information:Universitäts-HNO-KlinikLeipzig, GermanyCarola Standke, [email protected], ph +49 3419721700

The four-day course of systematic presentation of head andneck oncology focuses on current concepts in surgery, radiation oncology and medical oncology. The programme

includes lectures, workshops, active cadaver preparations andlife surgery. The course delivers current knowledge about standard procedures and controversies in head and neck oncology like adjuvant treatment, induction chemotherapy, immune oncology, organ preservation and de-escalation concepts in HPV positive oropharyngeal cancer. Furthermore,

functional aspects and surgical/phoniatric rehabilitation will beaddressed. Participants are integrated in active interdisciplinarydiscussions. Teaching in life surgeries and videos includes systematic in neck dissection, laryngeal partial resection techniques and surgery and approaches to different sites ofhead and neck. The course will therefore deliver concepts andraise awareness of evidence-based modern head and neck oncology.



4TH ESO-ESMO BREAST CANCER IN YOUNG WOMEN INTERNATIONAL CONFERENCE

DEADLINESABSTRACTS: 13 MAY 2018

EARLY REGISTRATION: 17 JUNE 2018LATE REGISTRATION: 23 SEPTEMBER 2018

6-8 October 2018 - Lugano, Switzerland Chair: O. Pagani, CH

Learning objectives:• In depth learning and update of the scientific and clinical

aspects of breast cancer in young women• Highlight the importance of multi-disciplinary management and

discuss difficult clinical cases• Focus on clinical research priorities and future perspectives,

involving patients’ advocates in setting the agenda • Participate in the discussion of consensus guidelines

Main topics:• Epidemiology of early and advanced disease• Biology • Hereditary breast cancer• Diagnostic tools and challenges• Loco-regional therapy• Systemic therapy • Psychosocial aspects and survivorship

Participant’s profile:• Medical oncologists• Surgeons• Gynecologists• Radiation oncologists• Breast radiologists• Onco-geneticists• Pathologists• Nurses• Patient advocates

Further information:Francesca Marangoni, [email protected], ph: +39 02 854 64525

Breast cancer in young women is a complex disease, occurring when these women are at the peak of their reproductive years, family life and careers. Being a

somewhat rare disease the optimal management of these patients is based on scientific data derived from clinical trialsmostly conducted on older women. Many aspects of breast cancer in young women are therefore poorly understood (e.g.etiology and biology among others) and research is muchneeded in this field. In addition, young women have many yearsahead of them to suffer the long-term effects of treatment and

specific survivorship issues (fertility and job among others). Thisfourth conference is a new opportunity for the latest updates onthis field and a platform for generating future research conceptsand collaborations. It will cover epidemiology, molecular biology,genetics, pathology, surgery, radiotherapy, systemic therapy, survivorship issues in young women with breast cancer. It will also include a consensus session that will form the basisfor a consensus guidelines manuscript to be published after theConference.


10TH CLINICAL ONCOLOGY UPDATE ONKOLOGIA 2018

REGISTRATION DEADLINES TO BE ANNOUNCED

October 2018 - Krakow, PolandScientific Coordinator: W.M. Wysocki, PL

Learning objectives:• Update on the most important advances in the field of gastroin-

testinal malignancies (including liver), breast cancer, melanoma,gynaecological malignancies and lung cancer

• Improve the skills and knowledge on practical clinical issues,such as management of common treatment-related toxicities,nausea and vomiting prophylaxis, cancer emergencies and spe-cific problems with immunotherapies

Main topics:• Lung cancer• Breast cancer (including disseminated disease)• Melanoma and other skin malignancies• Gastro-intestinal malignancies (including liver)• Gynaecological malignancies• Treatment-related toxicities

Participant’s profile:• Medical oncologists, radiation oncologists and surgical

oncologists• Other medical specialties involved in cancer care

(e.g. radiologists, pathologists, general practitioners, etc.)• Medical students and nurses

Further information:Medycyna Praktyczna - ConferencesLiszki, PolandMichał Bańdo, [email protected], ph +48 12 2934279

The 2018 conference programme will include special sessions designed for in-training oncologists with question-and-answer modules and simulated board

certification tests in oncology. It will furthermore offer plenarylectures delivered by the leading experts in the field, focusing onthe state-of-the-art therapies and concluding with take-homemessages. Lectures will cover the current standards of modernoncology, with special attention to practical aspects of effectivecancer treatment. Multidisciplinary interactive sessions will beopened also for non-oncologists dealing with cancer patients(radiologists, pathologists, general practitioners, etc.). The

conference will be held in English and further languages, forwhich simultaneous translation in English will be provided. European experts in oncology, invited jointly by ESO and Medycyna Praktyczna, will deliver lectures on practical clinicalissues, including management of patients with gastrointestinalmalignancies (including liver), current strategies in gynaecological oncology and advanced lung cancer, management of breast cancer (including novel therapeutic options), treatment of urinary tract malignancies, skin malignancies and oncological emergencies.



ESO-ASCO MASTERCLASS IN CLINICAL ONCOLOGY

DEADLINEBY APPLICATION ONLY: 15 JUNE 2018

10-13 November 2018 - Yerevan, Armenia Chairs: G. Curigliano, IT - F. Peccatori, IT

Host Chair: G. Tamamyan, AM

Learning objectives:• Advance participants’ knowledge in the treatment of breast,

gastrointestinal, gynaecologic, lung and prostate cancers• Encourage attendees to adopt a multidisciplinary approach to

the management of patients• Increase understanding of roles and responsibilities of

oncology team members in the delivery of quality cancer care

Main topics:• Breast cancer• Lung cancer • Gastro-intestinal cancers• Gynaecological cancers• Prostate Cancer

Participant’s profile:• Age between 25 and 40 years• At least 2-3 years’ experience in clinical oncology (medical

oncology, radiation oncology, surgical oncology)• Involvement in scientific activities (desirable)• At least intermediate level of English language (simple scientific

discussion in English)• Priority will be given to applicants practicing in Caucasus,

Eastern Europe, former Soviet Republics and Middle East.

Further information:A. Ciocchini, [email protected], ph +39 02 85464529D. Mengato, [email protected], ph +39 02 85464523

This clinical oriented educational programme has been designed for medical, surgical and radiation oncologists and,in the selection process, priority will be given to applicants

practicing in Caucasus, Eastern Europe, former Soviet Republicsand Middle East who wish to improve their knowledge and skills inmultidisciplinary cancer management. The programme will exposeparticipants to a full spectrum of issues in clinical oncology andpractice-oriented training, focusing on breast, gastro-intestinal, gynaecologic, lung and prostate cancers and furthermore includeprofessional development topics.

Experts will deliver state-of-the-art lectures on specific cancers followed by multidisciplinary tumour board discussions. Facultymembers and participants will discuss aspects of medical, surgical,and radiation therapeutic options and how they can be used together for optimal patient outcomes. Furthermore, participants will deliver clinical case presentationswithin small groups. Attendance will be by competitive applicationonly and admitted participants will be granted free registration andfull-board accommodation.


VISITING PROFESSORSHIP MEETINGS

Within the Eastern Europe and Balkan Region Programme, ESO is pleased to provide support forclinical institutes in the region to propose a Visiting

Professorship Meeting (VPM) and four VPM will be supported byESO per year. The selection will be made among suitable proposals on a first-come/first-served basis and further proposals will be assessed for the following year.

The Visiting Professor is a renowned expert in the clinical oncology topic and can adequately focus on the tumour typeand discipline.

The hosting clinical institute is a renowned centre of referencefor clinical oncology in the region whose medical team is

interested in attending and actively participating in an internaleducational meeting held in English. Whereas proposals by the Host Chair will be considered, theVPM is intended to span 1.5 days and the programme is discussed with the Visiting Professor. Clinical cases presented by the participants are mandatory partsof the programme.

Typically, a VPM is organised in a tumour type (for instanceprostate cancer) by a defined discipline (for instance, radiationoncology) and should be organized for 30‐50 participants. Themedical/clinical oncology team of the host institute is invited bythe Host Chair and attendance is free of charge. The Host Chair can also promote and invite the team of other institutes in the region/country.

Application:

To apply as Host Chair of a VPM please visit:www.eso.net/pagine-interne/visiting-professorship-meetings.html

Next planned events:

• Gastro-intestinal Cancer12-14 October 2017, Sarajevo, Bosnia and Herzegovina Venue: Oncology Clinic, Clinical Center University of SarajevoHost Chair: Professor Semir Beslija, BAVisiting Professor: Eric Vas Cutsem, BE

• Breast Cancer2018, Pristina, KosovoVisiting Professor: A. Eniu, RO

Further information:Laura Richetti, [email protected], ph +41 91 8200951


ESO OBSERVATORIES AND SESSIONS

ESO Observatories are high level sessions organised duringmajor international conferences with the aim of providingthe audience with updated an unbiased information on a

given topic. An ESO Observatory concentrates on a forecast of

what members of the panel expect to happen in their own fieldof competence and expertise in the coming period.The conclusions are published at www.eso.net.

The following Observatories will be organised:

• 5th Breast Cancer Observatory during the International Tehran Breast Cancer Congress, 18 October 2017, Tehran, Iran

• 5th Prostate Cancer Observatory during the 33rd Annual EAU Congress, 16 March 2018, Copenhagen, Denmark

• 5th Lung Cancer Observatory during the European Lung Cancer Conference, 13 April 2018, Geneva, Switzerland

• 15th Colorectal Cancer Observatory during the 20th World Congress on Gastrointestinal Cancer, 20 June 2018, Barcelona, Spain

Furthermore, ESO is proud to co-operate with major organisations in Europe and beyond by holding sessions in the programme

of their congresses:

• ESO-RUSSCO session at the 21th Russian Cancer Congress (RUSSCO 2017), 14-16 November 2017, Moscow, Russian Federation

• ESO supported session at the 19th World Congress of Psycho-oncology and Psyco-social Academy (IPOS 2017), 16 August 2017,

Berlin, Germany

• ESO session at the 4th International Oncology Forum “White Nights”, 15-17 June 2018, Saint Petersburg, Russian Federation

THE LIST INCLUDING SESSIONS CURRENTLYIN DEVELOPMENT WILL BE PUBLISHED IN THE

NEXT EDITION OF THE PROGRAMME


ESMO PRECEPTORSHIP ON IMMUNO-ONCOLOGY

Comprising plenary lectures by a multidisciplinary facultyof international experts and case-based sessions, ESMO Preceptorship courses offer an enriched learning

experience, thanks to their small size and emphasis on interaction with fellow participants and faculty.The courses are designed primarily for medical and clinical oncologists and aim to educate participants about the currentstandards of care. They are particularly suitable for young oncologists and for general oncologists wishing to update their

knowledge. Each course is accredited with ESMO-MORA CME(8-10 points). ESO is pleased to announce that a limited number of travelgrants are made available on a competitive basis to non-ESMOmembers interested in attending the ESMO Preceptorship on Immuno-Oncology courses in 2017 and 2018.ESMO members interested in travel support opportunities are invited to visit the ESMO website.

Learning objectives:• Understand the basics of tumour immunology• Learn about the essentials of immunotherapies and their

applications in cancer medicine• Learn about the status of development and clinical experience

of immunotherapy in different tumour types

Participant’s profile:• Medical and Clinical oncologists• Travel grants are made available to non-ESMO members. ESMO

member are invited to visit the ESMO website for further information on travel support

Next planned event:

• 3-4 November 2017, Zurich, Switzerland Chairs: R.A. Stahel, CH - J. Haanend, NL - S. Peters, CHApplication deadline: 20 August 2017

Further information:Luis Carvalho, [email protected], ph +41 91 8200958

Further courses scheduled in 2018 will be announced atwww.eso.net and www.esmo.org.

DEADLINEBY APPLICATION ONLY: 20 AUGUST 2017


2018 APPLICATION DEADLINESFIRST SEMESTER 2018: CLOSED

SECOND SEMESTER 2018: 6 NOVEMBER 2017

ESO’s Clinical Training Centres Programme aims at givingtrainee oncologists of the future the opportunity to spenda period of time in a clinical setting specially designed to

address their needs. Trainees can attend a selected host centre for a period of 3-6months with either ‘observership status’ (direct contact with

patients is not foreseen) or ‘residency status’ (direct contact withpatients is foreseen). During this period it is anticipated that participants will gain further knowledge in their specialty as wellas a good overview of all the issues involved in the running of asuccessful cancer unit.

The following centres have been selected as Clinical Training Centres:• St. Vincent’s University Hospital, Dublin, Ireland, under the umbrella of the University College Dublin• Institut Gustave Roussy, Villejuif, France, under the umbrella of University Paris-Sud• Oncology Institute of Southern Switzerland, Bellinzona, Switzerland• European Institute of Oncology, Milan, Italy• Istituto Nazionale dei Tumori, Milan, Italy• The Royal Marsden, NHS Foundation Trust, London, United Kingdom • The Christie, NHS Foundation Trust, Manchester, United Kingdom• Comprehensive Cancer Centre Ulm, Ulm, Germany • Champalimaud Clinical Centre, Lisbon, Portugal

Training programmes:Details of the training programmes offered by each centre can befound at www.eso.net under the ‘career development’ section.

Grant:Successful applicants will receive the following:

• Travel costs to and from country of residence• A monthly grant of EUR 2.300 for visiting observership status

and EUR 2.500 for visiting residency status.

Application:Details on the application and selection procedure can be foundonline.

Further information:Corinne Hall, [email protected], ph +39 02 85464523

CAREER DEVELOPMENT CLINICAL TRAINING CENTRES FELLOWSHIP PROGRAMME

The 2018 Clinical Training Centres programme will be supportedby a Fund provided by the European School of Oncology and aneducational grant from Bristol-Myers Squibb and GenomicHealth.

Nurses Fellowship Programme:ESO and the European Oncology Nursing Society (EONS) are offering a new fellowship programme for cancer nurses in Europe.Further information can be found at www.cancernurse.eu.


DEADLINEBY APPLICATION ONLY: 14 SEPTEMBER 2018

CAREER DEVELOPMENTCERTIFICATE OF COMPETENCE IN LYMPHOMA FOURTH COHORTChairs: J.O. Armitage, US - M. Hoechstetter, DE - F. Cavalli, CH - S. Stilgenbauer, DE

Programme:The Programme, which is offered on a part-time basis usingblended-learning modules and seminars, is divided in three attendance seminars (in Germany and Switzerland) and four e-learning modules.Over the duration of 14 months the Programme provides a totalof 405 hours of comprehensive learning, accordingly reportedwith a workload of 14 European Credit Transfer and AccumulationSystem Points (ECTS) by Ulm University.The current edition started in February 2017 and will conclude inApril 2018.

The European School of Oncology in co-operation with Ulm University offers a structured Certificate of Competence in Lymphoma Programme, an academically recognised

curriculum of studies, which was developed with the contribution of internationally recognised physicians and scientists in the field of haemato-oncology.

Eligibility:The Programme is designed for oncologists and haematologists(medical oncology, haematology, internal medicine, radiation oncology, pathology), but it is equally accessible to graduates innatural sciences who are engaged in the field of oncology, especially in the field of lymphoma.

Admission and deadlines:Admission to the Certificate of Competence in Lymphoma Programme is by competitive application only and the selectionis based on the eligibility criteria and the selection procedure. Attendance is limited to 20 participants per cohort.Applications for the fourth edition will open in mid-May 2018 andsubmission is required by the deadline of 14 September 2018.

Certificate:Upon successful completion of the Programme, participants willobtain an academic certificate issued by the European School ofOncology and Ulm University assigning 14 ECTS and a diplomasupplement by Ulm University.

Further information:Dolores Knupfer, [email protected], ph +41 91 8200952


DEADLINEBY APPLICATION ONLY: 14 SEPTEMBER 2018

CAREER DEVELOPMENTCERTIFICATE OF COMPETENCE IN BREAST CANCER

THIRD COHORTChairs: F. Cardoso, PT - J. Huober, DE - W. Janni, DE - O. Pagani, CH - F. Peccatori, IT - E. Winer, US

Programme:The Programme, which is offered on a part-time basis usingblended-learning modules and seminars, is divided in three attendance seminars (in Austria, Portugal and Germany) and fivee-learning modules.Over the duration of 13 months the Programme provides a totalof 381 hours of comprehensive learning, accordingly reportedwith a workload of 13 European Credit Transfer and AccumulationSystem Points (ECTS) by Ulm University.The current edition started in March 2017 and will conclude inApril 2018.

The European School of Oncology in co-operation with Ulm University offers a structured Certificate of Competence inBreast Cancer Programme, an academically recognised

curriculum of studies, which was developed with the contribution of internationally recognised physicians and scientists in the field of breast cancer.

Eligibility:The Programme is designed for physicians with experience in thefield of breast cancer (medical oncology, radiation oncology, gynaecology, senology, pathology), but it is equally accessible tograduates in natural sciences who are engaged in the field ofbreast cancer.

Admission and deadlines:Admission to the Certificate of Competence in Breast CancerProgramme is by competitive application only and the selectionis based on eligibility criteria and the selection procedure. Attendance is limited to 20 participants per cohort. Applicationsfor the third edition will open in mid-May 2018 and submission isrequired by the deadline of 14 September 2018.

Certificate:Upon successful completion of the Programme, participants willobtain an academic certificate issued by the European School ofOncology and Ulm University assigning 13 ECTS and a diplomasupplement by Ulm University.

Further information:Alexandra Zampetti, [email protected], ph +41 91 8200954

-tim

urricque cUni

ti ttard pudyStSt

e tsaM

a

eor lg farineplum pruc

ern i tam up inte tme – t

line er On A

ly!

in onsskaship tderae

l !allationti

ed OancAdv

.ylogo nc

ylogo Onc

S School Ch ll & I t d ti

oup: gretgarTTarts, slogio oncallinicC

iecatients, ser pancc

and the ylogo oncoff onc

al and locTimelyg arnineended llThe b

lo als. Itare seminacf

ine w an medic in humseduata gr

xperiith e wsgineer and entssenti

in their sderaeg lomin bec aim of f bec

g:arninee llibx flelyarneline-l onsseompri ceptoncg c

lyamiork, fine wombo cou tyswo

ate trarlylgue who r

d e in the fielenc

d. r fiel

o-e-tacg and fnin

.udyt and s

Sem

este

r 1st

er 2

Summer School

Clinical Research

Interdisciplinary Oncology

Challenges & Introductio

- Cellular and molecular biology of cancer- Diagnostics- Principles of therapy and treatment- Epidemiology

- Biometry- Clinical trials

on

er

an ientificcgh sHind ou fsam iogrThe pr

ssalop-cTs. ationniz

er Ulm a enter CancC

s.ieencompetc

orinute tlo-rlitpSelop devlyalificpecS

e. Ind lifalionsseofpr

quality:allinic nd cxwned eeno ralationern intyded b

th sh aucs, snertarg patinooper c

lo Onc of f OnclhooScan opeur nd the E

t:porupg snagg englyontr santsipticaror ped f

laie av arsson peractont cidual div

ag and ortsxper -

e ivsehenompr e C

h the enricylog

ed in their g

er swo ane tlabl

Sem

es

Sem

este

r 3

- Ethical aspects

Advanced/Integrated Therapies

- Project Management

- Clinical oncology I- Clinical oncology II- Integrated therapeutic concepts

apies

The

sis

ation D

p

atianizgal, orhnicect

am sogr prudytThe s

eergedcimedacaeht

sranimesecnadnetta

ruEehthtiwnoitarob

licpAp

15

p

stions quealionsseof and pralon

bero in Octtsart wdetelpmocsitI.

.«ecneicSforetsaM» oferaerehT

llocnienodnaytisrevinUmlUtas

.)OSE(gyolocnOfoloohcSnaepor

ldline: Apriae D th

.

htiw

r u

-a

Sem

este

r 4

Management

Summer School Future Perspectives

- Business basics- Health care systems- Management of processes, entities and people- Quality control

d people

Mas

ter`

s T

lo

bssaStr-hmidtSca Ut

ooncertsal: maie-M

de

er PhD gur | 731-500-69-Phone: +4

lm.ni-u@uyog

ww9408 6 ww

onw ertsa.mww

.ylogonc de

n

TIONAL ONLINEINTERNAATIONAL ONLINE MOGIC OLCYNAEGREE IN GDE

oiticreiD

l MDediaparrdiIgnacio Z Zapar. ityserAM Univsor Useofe Pratisoc. Asalpits Hoityser Univaz Unit, La Pylogo Onclogiconecy. GPhD

e.uttitsh Incarsee Ral - BiomedicAZor IdiPect Diranttsis AsientificSc

cenerreeffeeef rff r o ofsorrsthuA

TER MASYOGOLC ONC

etti lanni Av. GioDr / ant Amederic. Fr Dr / a Díazbece. R Dr /a edejTTejo trs Dieseloraría Doa. MDr / eno l-Moronio Gi. Ant Dr / b er GotliealtW. Dr

ezenít Bezzála Gontinsria. CDr / oponi a IacSar. Dr /icseKa nse. VDr / yatibag M. Mlau. P Dr / tínezara Mandrejl. A Dr /

omán Rtínezargio MSer. Dr / a umurats. Noriomi M Dr /sioacaleno Pa Mors. EliDr / dor aannon Salv. ShDr /

saise-IglhezSáncuíssé L. JoDr / cía aro GagSantiier de . Jav Dr /a geV de ernándeze ForrTTorra ier de l. JavDr / loagnoanZa annV. Dr

o

e ativorm a formsf peryy perlogo Onclogicoaecnyee in Ggreer Dtsaline MThe one edgwl and knoementlvovg, inarnineonnection, l the csouravh faction whic

ents.onta cltimedi mu high-quality y mutsough the beg thrdinluib

al, acticith a pr wsitieg activainin trsludese incourithin the ce wlh ModuacEs:ecsoure ralera sevived ementl aim impyoratipticare and pactiv

sloo tngg tinraeL

prityserniv and utssaliipec syeloped be devse arour the c of f the centsontThe c -or aj msente prllie, who wtigsewned prenoe and rxperiencide eith w wssorsef

h:carsee rientificc stseat the lntouco acg intinaka te on the arsnew

ff

sntsenteoC

e 1 lModu sicsaer BancCe 2 lModu er Ianc CalEndometrie 3 lModu er IIanc CalEndometrie 4lModu er Ianc CalicvervC

umoran tariv oantGi

al

s

C

Ts

eaeriat mudySt

quehniec talgicurideo sVeeduroc prallinicand c

aCxe

eTTest

e 5 lModu er IIanc CalicvervCe 6lModu er Iancan CariOve 7lModu er IIancan CariOve 8lModu er Iancar ClvuVe 9 lModu er IIancar ClvuVe 10lModu a omcerine SarUte 11lModu a omcerine SarcUte 12lModu er and humancC

ith wsudietse sasmentsses atxper

ngiteste R &ngist

Ia IIa

oductioneproan r msumors talc

eptsonc C

omdicina.ceoma.cn

s

g

M

F

sarieumme sactiverInt

gdinae ryarementlompC

Ma

aF

we-(+

snos lesrstea

s guidelinekac-trtsa

3 e 1lModu logionecye gyarRe 14lModu e Care CativlialP

meso.curswwww.cursl: ai-m insmedicsouro@cinf

2 10 34 35) 90+34


MEDIA ACTIVITIES

The aim of ESO’s media activities is to promote and reward intelligent and critical coverage of cancer and cultivate a

more positive but realistic image of the disease that is developed through several activities that are described herefter.

Cancer World Journalism AwardFew issues in Europe are more demanding of serious journalism than reporting on cancer. Almost one in two ofus will be diagnosed with the disease and may live with it for many years.Journalism that makes a difference should be celebrated. The Cancer World Journalism Award encouragesand rewards journalists who deliver insights into the personal and social impact of the disease, and efforts tochange policy, practice or advocacy.We are looking for journalists to submit one or more items of their work - whether in print, online, on radio,video or television - into the following categories:

• Patient and carer experience• Research, science and treatment• Policy, services and affordability • Prevention

Cancer World Journalist NetworkESO has created a Cancer World Journalist Network group on Facebook for cancer reporting journalists worldwide. Members of thegroup help, support and encourage each other to further develop their cancer reporting skills. They can also submit proposals for shortnews and opinion pieces for the Cancer World website as well as apply for a Cancer World Journalist Grant and be funded by ESO tocomplete a story on a cancer-related topic. Further information is available by contacting Corinne Hall - [email protected]

A prize of €1500 is available in each category. The journalist judged the overall winner will also be funded to attend the Award ceremony, where he/she will be presented with their award.

Find out more at http://cancerworld.net/media/cancerworld-journalism-award

09.14

ELELELJO JO O O ELELJO ELLJO JO ELELELELELELELELELELELLELELELELELELELELELELELELELELJO JO JO JO

’’’’SEEVIERSEVVIER’

NAL URN VIERSEVIER

URNAL SEVSEVSEVURNAL

EVIEREVIERSEURNAL A A URNAL U S VSEVIERSEVIERSEVSEVVIERVIERSEVSEVIERSEVIER’SESESESESEVIE ’SEVIERSEVIE ’’’SESESS ’SEVIERSEVIER’’VIERVIERVIEREVIERESEEEVIERUR UR RNAL RNAL UR RNAL U L URNA AL

’S ERSSEVIERSEVIERSEVIERRSEVIEREVIERSEVIERRRR’R’R’R’R’R’R’R’R’’R’

CO’ COS O’’ ONCO ONC ONCO ONCOS OS OS O ONCOS PU S ONCOS ONCS PUBL UBL UBL S ONCOS ONC ONCOS PUBL S S PUBL S O COS ONS ONC OS ONCOS ONCOS ONCOS ONCS ONCOS ONCO CO COS S ONCS ONCS ONCOS ONCOS O ONCOS ONCOS O ONCO OS ONCOS O ONCOS ONCS O ONCOS S PUBL S PUBL S PUBL S PUBL UBL S PU ’’’’’’’’’’’’’

OG OG O OGY OGY OGY Y OGY OGY O OG ISH ISH I ISH

O GY GY OG OG ISH S ISH O O O OGY O OG OG GY O OGY OGY OGY OLOG GY O OGY OGY OGY GY Y GY OGY OGY OGY OGY O OGY OGY ISH ISH ISH ISH ISH

OGY GY O O OL L OL OL OL OL OL OL OL OL OL OL OL OL OL OL OL OL OL OL OL OL L OL OL L

Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y

JO JO JO HI HI HI JO JO HI HI HI JO J JO JO JO JO JO JO JO JO HI HI JO JO O O J J JO JO J J HI HI HI HI HI HI HI HI HI JO JO O O HI HI HI HI HI J JO JO J HI HI HI HI

H QUURNAL URNAL URNAL

QU UGH GH GH QUURNAL NAL U G GH QGH QUH QUURNAL URNAL URNAL URNAL URNAL L UR UR UR URNAL G G GH QUGH QUURNAL NAL U U U RNAL RNAL RNAL L URNAL URNAL

UH QU QU QUGH Q UG QUGH QUGH QUGH QU QUH QUG GH QUGH QUGH QUGH QU GH QUGH QUGH QGH QUGH QRNAL RNAL RNAL URNAL URNAL

Q Q GH QU Q Q Q Q Q Q GH QUGH QUGH QU U U Q QURN

A UBL S PUBL S PUBL S PU

ALITY ALIT ALIT S PU S PUBL ALIT TY R TY R TY R ALIT S PUBL PUBL A ALITY R S PUBL S PUBL S PUBL S P S PU ALITY R ALIT S PUBL S PUBL PUBL PUBL PUBL S P S P S P S PUBL S PUBL ALITY R ALITY R A ALITY R ALITY R ALITY R ALITY R A A Y R ALITY R ALITY R A A ALITY R TY R ALIT Y R ALITY Y R TY ALIT ALITY R ALITY R TY R ALITY Y R S PUBL S PUBL S PUBL S PUBL S PU UBL UBL ALITY R ALI TY R AL LITY R AL LI TY R

ISH ISH ISH ARC

ISH RESEA EARC RESE RESEA

ISH ISH A RESEAR

ISH ISH ISH EARC EAR

ISH RESEA ARC

ISH ISH ISH ISH ISH ISH ISH RESEARC A ARC RESEA A RESEARC A RESEARC RESEARC RESEARC ARC ARC ARC RESEARC RESEARC RESEARC R R ARC ARC RESEA RC RC RESEARC ESEARC ESEARC R R R R RESE RESE RESEA A ARC A RESEA

ISH ISH ISH I ISH H ISH RESEARC RESEARC RESEARC RESEARC

CH CH CH CH CH C CH CH CH CH C CH CH CH C CH CH CH C CH C CH CH CH H CH CH H CH CH CH CH CH

op T

pre and res he T

EdiHT

Cited Articles:

all stages of f all stages ofevention, diagnosis and treatment breas of f breastd clinical research for the advancement

, which focuses on trans searchers and clinicians jo is an international, multidisciplinarye Breast t

atima Cardoso F-Chief:in-itorREAST BHE

. the disease of f the disease cancer st

slational urnal for

RC

Oan

r Pch A

fEH/OGYY/NCOL OINSWEVIE RRITICAL

theb the literature of f the literature A review cancer: and breastbesity

patients32,825 studies in 85nalysis ofA syst cancer: breastroliferation markers and survival in early

rognostic signi�cance and survivalhemotherapy: P breast histological grading system to assess response of f breast new

OGYOLTAATME

.com breastonline

- and meta tematic review

cancers to primary t

f s Uh T

Epop T

bycrit Cri Edi

G f f h I i l S ih k f CGA f f in older cancer patients: R comprehensive geriatric assessmentse of f comprehensive geriatric assessment

hyperthermiahe cellular and molecular basis of f hyperthermiarelated peptides and their receptors in human malignancies-ermal growth factorpid

Cited Articles:

experts from around the world. and hemat oncologytical reviews in all �elds of f oncology

publishes scholarlyematology/Heviews in Oncology y/Hitical RAapro atti S. M-chief:in-itor

.com-onlinecroh (SIOG) iatric Oncology y (SIOG)

ecommendations tients: R

n human malignancies

written tology, scholarly

Sign u

th visitFor inf

p for the OncologyAdv

he journal webpage formation on how w

fro

vance newsletter

. e your pap to submit

th the task force on CGA of f the International Societyom

, per

Ger of f Geriatric Oncology he International Society y of

OVisit

OncologyAdvanc

.com ce

Publishing content from internationally renowned clinical academics and researchers, Nature Reviews Clinical Oncology is a valuable resource for practicing doctors, researchers and academics within the field.

We publish:

Reviews and Perspectives - authoritative, up-to-date information on a topic, placing it in the context of a field’s history and development. News & Views and Comment articles - topical discussion and opinions. Research Highlights - selected primary research from a range of specialty and general medical journals.

Content recently published in the journal includes:

Integrating liquid biopsies into the management of cancerGiulia Siravegna, Silvia Marsoni, Salvatore Siena & Alberto Bardellidoi:10.1038/nrclinonc.2017.14

Tumour-associated macrophages as treatment targets in oncologyAlberto Mantovani, Federica Marchesi, Alberto Malesci, Luigi Laghi & Paola Allavenadoi:10.1038/nrclinonc.2016.217

EMT, CSCs, and drug resistance: the mechanistic link and clinical implicationsTsukasa Shibue & Robert A. Weinberg doi:10.1038/nrclinonc.2017.44

To view more of our content, learn about the journal scope or sign up for free e alerts, visit the website.

nature.com/nrclinonc

facebook.com/NatureReviews @NatRevClinOncol

COMBINE AND CONQUERChallenges of combining targeted therapies in clinical trials

Cancer metabolism:

Important targets revealed

CLINICAL ONCOLOGYJanuary 2017 volume 14 no. 1 www.nature.com/reviews

De Vita and Canellos, US

Cassinelli, Italy

Imbimbo and Blackhall, Italy/UK

Banerjee, UK

Cremolini, Italy

Kaasa, Norway

Viviani and Pileri, Italy

Benjamin, US

Bellmut, US

Valdagni, Italy

Licitra, Italy

Barr and Bleyer, US

Heng et al, US

The “Gianni Bonadonna Lecture Series”

2016

2017

2018

TJ TumoriJournal

ESO Recommended

Impact Factor: 1.233

?t eugelloct

repxetsaerbk catnocylciuqotdeeN

BrkkoN twNetserentCstaeBr

aerBS yggyrenyS

?at

krowteNsertneCtsastinUtsaerBgnomay

fotcejoojrpA

i

imt’noD

tanretninidroccaBruoysI

s

e

s

nutroppoehtssi

dradnatslh

anois t-fo-etatso

atgn

t grotinUsaerB

?

ytin

stra-ehdesina

n !tinUm

tsaerBruoyo idnaeromrevocsidot

aB

erBaemoceB

evorpm

sNC

ertneCtsa

rkN

ebmeMkrowtweN

effidnAatslanoitanretnitr-fo-etatsehttsacdaorbptahtyrotceriDtinUtsaerBenilnonareffoeW

neCtsaerBrofmargorPnoitatiderccAlanoitaNuEehtdna)noitilaoCrecnaCtsaerBnaeporuE(onoitasinagrO.sertneclarreferderedisnocebpicsiditluM(stsinUtsaerBsedulcnikrowtenruO

rowehttuohguorhtdnaeporuEnieracrecnacSEfotcejoojrpasitI.recnactsaerbfotnemtaertnoitanretnitsrifehtsikrowteNsertneCtsaerB

eMaerB.www

a-eht

!ee!niinlli

seesrttrnnteenc00220

naanhattheroM

O!retnecruoyotecnereaekamyllaerll’tidn

.eracrecnactsaerbyranilpicsiditlumrofsdradnaottpmettananisrebmemruotuobaecnalgatanoitamrofnideliatedsedivorp

.srsetnehtybdereffosinoitatiderccaretnectsaerb,SUehtnI.tnemailraPnaeporuannoDaporuE,AMOSUEybdednemmocersistinUtsaerByranilpicsiditluMfoot)etaGytilibigilEees(sttsnemeriuqermuminimllfiluftaht)sertneCtsaerByranilp

.dlrtsaerbevorpmidnaetomorpotmiaehthtiw)yggyolocnOfoloohcSnaeporuE(OS

dnasisongaidehtotdetacidedylevisulcxesertneclacinilcfokrowtenla

!eerfsipihsrebmegro.krowteNsertneCtsa

SEES_NCB#

!LL!AALICOSOG

eniinllinnlo2

www.prostatecancerunits.orgMembership is free!

Prostate Cancer Units Network is the first international network of clinical units dedicated to the diagnosis and treatment ofprostate cancer. The project is an initiative of the European School of Oncology in partnership with Europa Uomo - the EuropeanProstate Cancer Coalition - with the aim to promote the multidisciplinary and multiprofessional management of prostate cancerpatients. Our network includes Prostate Cancer Units that fulfil minimum requirements (see Eligibility Gate) to be consideredreferral centres. This website offers an online Prostate Cancer Units Directory that provides detailed information about our membersin the attempt to broadcast the state-of-the-art standards for multidisciplinary prostate cancer care.

And it’ll really make a difference to your unit!

Photo: Sunflower - Photographer: © 2009 Mikael Hvidtfeldt Christensen

Prostate Cancer Units NetworkSynergy among Prostate Cancer Units

Is your Prostate Cancer Unit organised with a multidisciplinary and multiprofessional team of experts and according to state-of-the-art international standards?

Don’t miss the opportunity to discover more and improve your Prostate Cancer Unit!

Become a Prostate Cancer Units Network Member

Prostate Cancer Units Network is a project of:

In partnership with and with the endorsement of


FOUNDERS L. Del Drago, RomeU. Veronesi, Milan†

BOARD OF DIRECTORS

President U. Rock, Milan

Members M. Alloisio, Milan A. Azario, MilanP. Biandrino, MilanA. Costa, Milan (CEO)V. Finizzola, MilanT. Galdy, FlorenceF. Gubitosi, MilanP. Maestro, MilanL. Pellegrini, RomeR. Tarricone, MilanG. Ventura, MilanL. Vita Samory, Milan

Auditors M.B. Lovati, Milan (Chairman)B. Negri, MilanS. Sarubbi, Milan

SCIENTIFIC COMMITTEE 2017-2019

Chairman F. Cavalli, Bellinzona

CEO A. Costa, Milan and Lugano

Scientific Director F.A. Peccatori, Milan

Members A. Albini, MilanF. Calvo, MadridA.M.M. Eggermont, ParisS. Kaye, SuttonP. Naredi, GöteborgL. Norton, New YorkC. Rolfo, AntwerpL. Sharp, Stockholm (EONS)S. Stilgenbauer, UlmE.P. Winer, BostonP. Workman, Sutton

WORLD ONCOLOGY FORUM 2017 COMMITTEE

Chair F. Cavalli, Bellinzona

Members A.M.M. Eggermont, ParisM. Gospodarowicz, TorontoY.L. Qiao, BeijingR. Sullivan, LondonE. Trimble, RockvilleC.P. Wild, LyonP. Workman, Sutton

DEPARTMENT COORDINATORS

A. Costa, Milan and Lugano Cancer World

N. Pavlidis, Ioannina Masterclass Clinical/Medical Oncology

M. Siano, St. Gallen e-ESO

M. Aapro, Geneva Sharing Progress in Cancer Care (SPCC)

F. Cavalli, Bellinzona World Oncology Forum

PROGRAMME COORDINATORS

A. Eniu, Cluj-Napoca Eastern Europe and Balkan Region

(EEBR)

D. Zaridze, Moscow Eurasia

M. Aapro, Geneva Latin America and Arab Countries

F. Cardoso, Lisbon Breast Cancer

E. Felip, Barcelona Lung Cancer

E. Zucca, Bellinzona Lymphoma

R. Valdagni, Milan Prostate Cancer

P. Casali, Milan Rare Tumours

TEAM

Chief Operating Officer C. Melcher

Administration Office L. Camarini, P. Gatti

Latin-AmericanProgramme and Event Organisation L. Carvalho

Editorial Office J. Costa Buranelli

Event Organisation A. Ciocchini, E. Fiore, L. Richetti

Rare Tumours Programme M. Fregonese

Editorial and Media Office, Clinical Training Centres Fellowship Programme C. Hall

EEBR, Lymphoma Programmeand Event Organisation D. Knupfer

Communication G. Maggini

Breast Cancer Programme, e-ESO and Event Organisation F. Marangoni

SPCC, Eurasia Programmeand Event Organisation D. Mengato

Bibliography W.S. Russell-Edu

Prostate Cancer Programme, ABC Global Alliance andEvent Organisation R. Ventura

WOF, CCB and Event Organisation A. Zampetti

TEAM AND WHO’S WHO AT ESO (2017)

ESO is supported by

Fondazione per la Formazione Oncologica, President: S. Gandini, Milan

ESO Foundation, President: C. Maggini, Bellinzona


www.eso.net

@ESOncology

www.facebook.com/ESOncology

http://linkd.in/1JH7IbG

www.youtube.com/TheESOChannel

MilanVia Turati, 2920121 Milano - ItalyPhone: +39 02 8546451Fax: +39 02 [email protected]

BellinzonaPiazza Indipendenza, 26500 Bellinzona - SwitzerlandPhone: +41 91 8200950Fax: +41 91 [email protected]

Departments

[email protected]

Masterclass Clinical/Medical [email protected]

Cancer World [email protected]

Sharing Progress in Cancer [email protected]

World Oncology [email protected]

Programmes

Arab [email protected]

Breast [email protected]

Eastern Europe and Balkan Region [email protected]

[email protected]

Latin [email protected]

Lung [email protected]

[email protected]

Prostate [email protected]

Rare [email protected]

MilanVia Turati, 2920121 Milano - ItalyPhone: +39 02 8546451Fax: +39 02 [email protected]

BellinzonaPiazza Indipendenza, 26500 Bellinzona - SwitzerlandPhone: +41 91 8200950Fax: +41 91 [email protected]

@ESOncology www.facebook.com/ESOncology

http://linkd.in/1JH7IbG www.youtube.com/TheESOChannel

www.eso.net

Documents

The European School of Oncology continues the consolidated